Liberty Health Sciences Total Assets 2020-2019 | LHSIF

Liberty Health Sciences total assets from 2020 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
Liberty Health Sciences Annual Total Assets
(Millions of US $)
2019 $105
2018 $105
Liberty Health Sciences Quarterly Total Assets
(Millions of US $)
2019-11-30 $149
2019-08-31 $130
2019-05-31 $115
2019-03-31 $115
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.127B $0.008B
Liberty Health Sciences Inc. is engaged in pharmaceutical grade marijuana production. The Company's principal business activity is the production and distribution of medical cannabis through its wholly owned subsidiary Liberty Health Sciences Florida Ltd. Liberty Health Sciences Inc. is based in Toronto, Canada.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $180.151B 33.80
Medtronic (MDT) Ireland $129.744B 21.07
Stryker (SYK) United States $70.689B 27.41
Boston Scientific (BSX) United States $54.208B 31.31
Lonza Group Ag (LZAGY) Switzerland $46.923B 0.00
Baxter (BAX) United States $40.686B 24.88
Terumo (TRUMY) Japan $29.500B 37.71
EssilorLuxottica Societe Anonyme (ESLOY) France $28.431B 0.00
Zimmer Biomet Holdings (ZBH) United States $27.536B 22.85
ResMed (RMD) United States $25.392B 36.87
Sunny Optical Technology (SNPTF) China $20.566B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $17.936B 0.00
Bio-Rad Laboratories (BIO) United States $15.588B 70.50
Insulet (PODD) United States $13.905B 612.28
Shandong Weigao Medical Polymer (SHWGF) China $12.436B 0.00
Quidel (QDEL) United States $11.970B 63.41
DiaSorin S.p.A (DSRLF) Italy $11.312B 0.00
GN STORE NORD (GNNDY) Denmark $8.157B 41.58
William Demant Holdings (WILYY) Denmark $7.457B 0.00
Perrigo (PRGO) Ireland $6.887B 11.82
Canopy Growth (CGC) Canada $6.498B 0.00
Hill-Rom Holdings (HRC) United States $6.424B 15.94
Hutchison China MediTech (HCM) Hong Kong, SAR China $4.287B 0.00
Neogen (NEOG) United States $4.258B 71.14
GW Pharmaceuticals (GWPH) United Kingdom $4.101B 0.00
Haemonetics (HAE) United States $3.835B 25.56
ICU Medical (ICUI) United States $3.703B 27.01
Envista Holdings (NVST) United States $3.620B 24.68
Abcam (ABCZY) $3.495B 0.00
Agios Pharmaceuticals (AGIO) United States $2.999B 0.00
NuVasive (NUVA) United States $2.702B 37.66
National Vision Holdings (EYE) United States $2.669B 415.63
TG Therapeutics (TGTX) United States $2.291B 0.00
DFB Healthcare Acquisitions (AHCO) United States $1.915B 176.38
AtriCure (ATRC) United States $1.909B 0.00
MacroGenics (MGNX) United States $1.485B 0.00
NanoString Technologies (NSTG) United States $1.360B 0.00
Aphria (APHA) Canada $1.341B 0.00
Aurora Cannabis (ACB) Canada $1.190B 0.00
Cerus (CERS) United States $1.180B 0.00
Cardiovascular Systems (CSII) United States $1.090B 0.00
PetIQ (PETQ) United States $1.064B 30.73
Meridian Bioscience (VIVO) United States $1.040B 39.18
Quanterix (QTRX) United States $0.993B 0.00
InMode (INMD) Israel $0.992B 25.03
Lantheus Holdings (LNTH) United States $0.871B 12.06
Owens & Minor (OMI) United States $0.843B 18.87
Vapotherm (VAPO) United States $0.833B 0.00
Phibro Animal Health (PAHC) United States $0.831B 16.57
OraSure Technologies (OSUR) United States $0.812B 0.00
Omeros (OMER) United States $0.760B 0.00
BioLife Solutions (BLFS) United States $0.660B 344.50
Eagle Pharmaceuticals (EGRX) United States $0.650B 46.56
Surmodics (SRDX) United States $0.643B 70.58
VAREX IMAGING (VREX) United States $0.631B 15.66
LeMaitre Vascular (LMAT) United States $0.589B 36.05
Zynex (ZYXI) United States $0.584B 50.97
Cytosorbents (CTSO) United States $0.410B 0.00
Viemed Healthcare (VMD) United States $0.390B 13.94
Neptune Wellness Solutions (NEPT) Canada $0.325B 0.00
HEXO (HEXO) $0.323B 0.00
Utah Medical Products (UTMD) United States $0.294B 25.24
InfuSystems Holdings (INFU) United States $0.251B 139.22
Organigram Holdings (OGI) Canada $0.220B 0.00
Female Health (VERU) United States $0.210B 0.00
Chimerix (CMRX) United States $0.200B 0.00
Exagen (XGN) United States $0.176B 0.00
Bovie Medical (APYX) United States $0.170B 0.00
Surface Oncology (SURF) United States $0.167B 0.00
Fonar (FONR) United States $0.161B 14.29
Wound Management Technologies (SMTI) United States $0.160B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.117B 0.00
Rockwell Medical (RMTI) United States $0.116B 0.00
Evolus (EOLS) United States $0.115B 0.00
Capricor Therapeutics (CAPR) United States $0.113B 0.00
Chembio Diagnostics (CEMI) United States $0.110B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.091B 0.00
MTech Acquisition (KERN) United States $0.088B 0.00
Nephros (NEPH) United States $0.072B 0.00
United-Guardian (UG) United States $0.068B 15.85
Brainsway (BWAY) Israel $0.066B 0.00
Trinity Biotech (TRIB) Ireland $0.063B 0.00
ImmuCell (ICCC) United States $0.040B 0.00
GUARDION HEALTH (GHSI) United States $0.035B 0.00
Akers Biosciences Inc (AKER) United States $0.034B 0.00
FSD PHARMA INC (HUGE) Canada $0.026B 0.00
NF Energy Saving (BIMI) China $0.022B 0.00
Myomo (MYO) United States $0.011B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
Senestech (SNES) United States $0.007B 0.00